Highlights and Quick Summary
- Total non-current assets for the quarter ending June 30, 2023 was $1.4 Billion (a -18.94% decrease compared to previous quarter)
- Year-over-year quarterly Total non-current assets decreased by -21.73%
- Annual Total non-current assets for 2022 was $1.96 Billion (a 15.95% increase from previous year)
- Annual Total non-current assets for 2021 was $1.69 Billion (a -0.02% decrease from previous year)
- Annual Total non-current assets for 2020 was $1.69 Billion (a 2.82% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current assets of Emergent Biosolutions Inc.
Most recent Total non-current assetsof EBS including historical data for past 10 years.Interactive Chart of Total non-current assets of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Total non-current assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $1,401.1 | $1,728.5 | – | – | – |
| 2022 | $1,955.9 | $1,790.0 | $1,651.2 | $1,680.1 | $1,955.9 |
| 2021 | $1,686.9 | $1,756.0 | $1,753.1 | $1,719.0 | $1,686.9 |
| 2020 | $1,687.3 | $1,657.5 | $1,670.2 | $1,652.1 | $1,687.3 |
| 2019 | $1,641.1 | $1,633.8 | $1,628.6 | $1,625.2 | $1,641.1 |
| 2018 | $1,608.6 | $610.48 | $597.58 | $591.82 | $1,608.6 |
| 2017 | $584.8 | $468.17 | $460.74 | $462.47 | $584.8 |
| 2016 | $459.89 | $452.03 | $528.42 | $507.74 | $459.89 |
| 2015 | $500.07 | $503.06 | $507.84 | $512.03 | $500.07 |
| 2014 | $506.52 | $485.66 | $491.8 | $496.05 | $506.52 |
| 2013 | $353.52 | $361.45 | $307.46 | $301.31 | $353.52 |
| 2012 | $300.88 | $287.09 | – | – | $300.88 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic